Conversation with The Cancer Letter

Candace Johnson: A New Vision for Roswell Park

Since Candace Johnson’s appointment as president and CEO of the Roswell Park Cancer Institute in February 2015, the institute has recruited 22 new faculty members and promoted 19 faculty members into senior leadership positions.

“I’m a new leader. I have a new style, a new vision of where Roswell Park is going,” Johnson, the Wallace Family Chair in Translational Research, said to The Cancer Letter. “We have new and different challenges, and unless my entire workforce understood these challenges and embraced the changes I’ve been implementing, we wouldn’t have a chance.”

• RPCI's Recent Recruitments and Promotions

ASCO Cervical Cancer Guideline Addresses Global Disparities

The American Society of Clinical Oncology issued its first clinical practice guideline for invasive cervical cancer.

The guideline provides evidence-based recommendations for four tiers based on available resources for cervical cancer screening and treatment: basic, limited, enhanced and maximal. For each setting, and for each stage of cervical cancer, the guideline recommends optimal therapy and palliative care. The guideline was published in the Journal of Global Oncology and was endorsed by the Society of Gynecologic Oncology.

Survey: 28 Percent of Doctors See Clinical Trials as Last Resort

Only 40 percent of Americans have a positive overall impression of clinical trials, according to a national survey conducted for Memorial Sloan Kettering Cancer Center.

The survey, which polled over 2,100 people including nearly 600 physicians, found that 28 percent of doctors considered clinical trials as treatments of last resort.

• Northwestern to host 5k coinciding with ASCO's annual meeting in Chicago

• The Canadian Cancer Society and Merck to collaborate on New Horizons project

• American Skin Association presents annual awards

• Margaret Foti honored by Ovarcome foundation

• Seattle Children's and Juno Therapeutics to collaborate on T-cell immunotherapies

• Memorial Sloan Kettering and Hunter Douglas establish graduate fellowship

• University of Chicago and Blue Cross and Blue Shield launch oncology medical home

• Lightpoint Medical signs agreement for Beta Emission Tomography technology from University of Arizona researchers

• CHMP issues positive opinion for Kyprolis in multiple myeloma

• ProNAi Therapeutics and Carna Biosciences to commercialize AS-141